Active options: MRNA AMD AVGO PLTR GOOGL NFLX PFE SOFI NBIS COIN
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Wall St set for muted open as tech stocks take a breather
- Oil steadies on rise in Middle East crude exports and G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
Moderna (MRNA) PT Raised to $89 at Morgan Stanley
August 19, 2026 4:23 PM EDTMorgan Stanley analyst Terence Flynn raised the price target on Moderna (NASDAQ: MRNA) to $89.00 (from $39.00) while maintaining a Equalweight rating.
The analyst comments "We are Equal-weight Moderna. While we believe there is long-term upside for Moderna, we believe the significant valuation increase... More
